Cargando…

High Expression Levels of CDK1 and CDC20 in Patients With Lung Squamous Cell Carcinoma are Associated With Worse Prognosis

Purpose: Progress related to the early detection and molecular targeted therapy of lung squamous cell carcinoma (LUSC) remains limited. The goal of our study was to identify key candidate indicators of LUSC. Methods: Three microarray datasets (GSE33532, GSE30219 and GSE19188) were applied to find di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Huan, Hang, Qingqing, Shen, Dijian, Ying, Hangjie, Zhang, Yibi, Qian, Xu, Chen, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292837/ https://www.ncbi.nlm.nih.gov/pubmed/34307447 http://dx.doi.org/10.3389/fmolb.2021.653805

Ejemplares similares

Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation
por: Deng, Huan, et al.
Publicado: (2021)

Biological and Pathological Implications of an Alternative ATP-Powered Proteasomal Assembly With Cdc48 and the 20S Peptidase
por: Esaki, Masatoshi, et al.
Publicado: (2018)

Significance of Parkinson Family Genes in the Prognosis and Treatment Outcome Prediction for Lung Adenocarcinoma
por: Li, Yanqi, et al.
Publicado: (2021)

An Immune-Gene-Based Classifier Predicts Prognosis in Patients With Cervical Squamous Cell Carcinoma
por: Yang, Huixia, et al.
Publicado: (2021)

Identification of a Novel Tumor Microenvironment–Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2020)

Identification of HOXA1 as a Novel Biomarker in Prognosis of Head and Neck Squamous Cell Carcinoma
por: Li, Hui, et al.
Publicado: (2021)

Effective TME-related signature to predict prognosis of patients with head and neck squamous cell carcinoma
por: Wan, Lingfei, et al.
Publicado: (2023)

CDK6 is essential for mesenchymal stem cell proliferation and adipocyte differentiation
por: Hu, Alexander J., et al.
Publicado: (2023)

Targeting of client proteins to the VCP/p97/Cdc48 unfolding machine
por: Meyer, Hemmo, et al.
Publicado: (2023)

Decreased CDKL2 Expression in Clear Cell Renal Cell Carcinoma Predicts Worse Overall Survival
por: Chen, Zhan, et al.
Publicado: (2022)

A Mighty “Protein Extractor” of the Cell: Structure and Function of the p97/CDC48 ATPase
por: Ye, Yihong, et al.
Publicado: (2017)

SNX20AR/MiRNA-301a-3p/SNX20 Axis Associated With Cell Proliferation and Immune Infiltration in Lung Adenocarcinoma
por: Yuan, Yixiao, et al.
Publicado: (2021)

CCR7 Has Potential to Be a Prognosis Marker for Cervical Squamous Cell Carcinoma and an Index for Tumor Microenvironment Change
por: Tian, Wei-Jie, et al.
Publicado: (2021)

Identification and validation of a novel tumor driver gene signature for diagnosis and prognosis of head and neck squamous cell carcinoma
por: Liu, Shixian, et al.
Publicado: (2022)

Rapid Cdc13 turnover and telomere length homeostasis are controlled by Cdk1-mediated phosphorylation of Cdc13
por: Tseng, Shun-Fu, et al.
Publicado: (2009)

Thicker Ice Improves the Integrity and Angular Distribution of CDC48A Hexamers on Cryo-EM Grids
por: Huntington, Brandon, et al.
Publicado: (2022)

Management and Prognosis of Interstitial Lung Disease With Lung Cancer (ILD-LC): A Real-World Cohort From Three Medical Centers in China
por: Xiaohong, Xie, et al.
Publicado: (2021)

An Extracellular Matrix-Based Signature Associated With Immune Microenvironment Predicts the Prognosis and Therapeutic Responses of Patients With Oesophageal Squamous Cell Carcinoma
por: Zhang, Hongpan, et al.
Publicado: (2021)

MICAL2 Facilitates Gastric Cancer Cell Migration via MRTF-A-Mediated CDC42 Activation
por: Wang, Yueyuan, et al.
Publicado: (2021)

Identifying Common Genes Related to Platelet and Immunity for Lung Adenocarcinoma Prognosis Prediction
por: Zhou, Chengmao, et al.
Publicado: (2020)

Construction of a Two-Gene Immunogenomic-Related Prognostic Signature in Lung Squamous Cell Carcinoma
por: Zhang, Xiaoting, et al.
Publicado: (2022)

CDK13-Mediated Cell Cycle Disorder Promotes Tumorigenesis of High HMGA2 Expression Gastric Cancer
por: Wu, Zhouying, et al.
Publicado: (2021)

p53–GSDME Elevation: A Path for CDK7 Inhibition to Suppress Breast Cancer Cell Survival
por: Wang, Yueyuan, et al.
Publicado: (2021)

Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma
por: Liu, Wenting, et al.
Publicado: (2021)

MicroRNA-125b-5p Correlates With Prognosis and Lung Adenocarcinoma Progression
por: Tang, Lin, et al.
Publicado: (2022)

Identification of the Prognostic Value of Tumor Microenvironment-Related Genes in Esophageal Squamous Cell Carcinoma
por: Zhang, Donglei, et al.
Publicado: (2020)

Construction of the miRNA-mRNA Regulatory Networks and Explore Their Role in the Development of Lung Squamous Cell Carcinoma
por: Fan, Xingchen, et al.
Publicado: (2022)

A Low Advanced Lung Cancer Inflammation Index Predicts a Poor Prognosis in Patients With Metastatic Non–Small Cell Lung Cancer
por: Lu, Ping, et al.
Publicado: (2022)

Pan-Cancer Analyses Reveal Prognostic Value of Osteomimicry Across 20 Solid Cancer Types
por: Yang, Changsheng, et al.
Publicado: (2020)

Identification and Validation of Immune-Related Gene Signature for Predicting Lymph Node Metastasis and Prognosis in Lung Adenocarcinoma
por: Jia, Ran, et al.
Publicado: (2021)

Reconstruction and Analysis of the Immune-Related LINC00987/A2M Axis in Lung Adenocarcinoma
por: Ma, Jiakang, et al.
Publicado: (2021)

Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer
por: Jiang, Minxiao, et al.
Publicado: (2021)

Development and Validation of a 7-Gene Inflammatory Signature Forecasts Prognosis and Diverse Immune Landscape in Lung Adenocarcinoma
por: Nai, Aitao, et al.
Publicado: (2022)

Molecular Simulation of Oncostatin M and Receptor (OSM–OSMR) Interaction as a Potential Therapeutic Target for Inflammatory Bowel Disease
por: Du, Qingqing, et al.
Publicado: (2020)

A Metabolism-Related Radiomics Signature for Predicting the Prognosis of Colorectal Cancer
por: Cai, Du, et al.
Publicado: (2021)

MiR-490-3p Silences CDK1 and Inhibits the Proliferation of Colon Cancer Through an LLPS-Dependent miRISC System
por: Qin, Da, et al.
Publicado: (2021)

Coexisting EGFR and TP53 Mutations in Lung Adenocarcinoma Patients Are Associated With COMP and ITGB8 Upregulation and Poor Prognosis
por: Zheng, Chang, et al.
Publicado: (2020)

Identification of TRPM2 as a Marker Associated With Prognosis and Immune Infiltration in Kidney Renal Clear Cell Carcinoma
por: Sun, Lei, et al.
Publicado: (2022)

Metabolomic Characterization Reveals ILF2 and ILF3 Affected Metabolic Adaptions in Esophageal Squamous Cell Carcinoma
por: Zang, Bin, et al.
Publicado: (2021)

Alternative Splicing Regulator RBM20 and Cardiomyopathy
por: Watanabe, Takeshi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tl81p3r5i5s3n2ajs14n8rrr3e